Home
Contact
About Myeloma MRD
Agenda
Faculty
Supporter Opportunities
Register for Livestream
Meeting Highlights
Home
Contact
About Myeloma MRD
Agenda
Faculty
Supporter Opportunities
Register for Livestream
Meeting Highlights
Meeting Highlights
MRD testing in smoldering myeloma: new horizons!
New insights on MRD negativity in newly diagnosed myeloma
MRD driven treatment trials
MRD in relapsed/refractory myeloma
Emerging MRD technologies
MRD testing in smoldering myeloma: new horizons!
Meletios Dimopoulos: From CENTAURUS to AQUILA trials
Shaji Kumar: ASCENT trial
Omar Nadeem: Immuno-PRISM and CAR-PRISM trials
Ola Landgren: REVIVE trial
New insights on MRD negativity in newly diagnosed myeloma
Neha Korde: MANHATTAN trial, long-term update
Hang Quach: MagnetisMM-6 trial update
Marc Raab: MajesTEC-5 trial
Kellye Koubek: ADVANCE 2.0 trial
Robert Orlowski: LINKER-MM4 trial
MRD driven treatment trials
Adam Cohen: STEM trial
Dickran Kazandjian: ImmunoPLANT trial
Luciano Costa: MASTER-2 trial
MRD in relapsed/refractory myeloma
Vania Hungria: DREAMM-7 trial
Juan Du: FAST CAR-T trial
Maria-Victoria Mateos: RedirecTT-1 trial
Krina Patel: iMMagine-1 trial
Benjamin Diamond: ReKInDLE study
Emerging MRD technologies
Malin Hultcrantz: ClonoSEQ MRD data update
Katie Thoren: Update on MALDI TOF MS and clonotypic peptides
Gary Ulaner: CD38 targeted immunoPET
